TP53 and cancer: Glycolysis in cancer cells is additionally controlled by Akt, which impedes PCD by restraining two BCL-2 pro-apoptotic family proteins, namely glycogen synthase kinase 3 (GSK-3), p53 upregulated modulator of apoptosis (PUMA).